论文部分内容阅读
目的探讨心房颤动合并冠心病的药学监护点和规范化的药学监护模式。方法临床药师以1例心房颤动合并冠心病患者的用药为切入点,利用药物相互作用、不良反应等药学知识,参与药物治疗方案的选择,实施药学监护。结果与结论心房颤动合并冠心病患者往往用药较为复杂,临床药师应围绕患者的抗凝方案,关注药物的相互作用,监测药物不良反应,用药教育则应以华法林和冠心病二级预防为主。
Objective To investigate the pharmacy care points and standardized pharmacy care mode of atrial fibrillation with coronary heart disease. Methods Clinical pharmacists took one patient with atrial fibrillation and coronary heart disease as the starting point, took part in the selection of drug treatment programs and implemented the pharmacy monitoring by using the drug interactions such as drug interactions and adverse reactions. Results and Conclusion Atrial fibrillation complicated by coronary heart disease patients often medication is more complex, clinical pharmacists should focus on patients with anticoagulant programs, focusing on drug interactions, monitoring adverse drug reactions, medication education should be warfarin and coronary heart disease secondary prevention the Lord.